To inhibit the tumor invasion and metastasis mediated by TGF-β ligand such as ActA, LNPs encapsulating follistatin mRNA were delivered to cancer cell clusters in the peritoneal cavity, reducing ActA levels and alleviating ActA-caused cachexia. The gene discussed is ACTA1; the disease is cancer.